Sleep drug may increase risk of falls, study finds

11/20/2012 | U.S. News & World Report

Mayo Clinic researchers examined data on more than 16,000 hospitalized patients in the U.S., and found that those who received the sleeping pill Ambien, or zolpidem, fell at a rate four times greater than those who didn't receive the treatment. Due to the research, Mayo is transitioning to other sleep-enhancement treatments, said Dr. Timothy Morgenthaler, Mayo's chief patient safety officer.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC